Notable is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers. Notable’s testing platform combines machine learning, automation and high-throughput screening directly on patient samples to predict responses to potential therapies, and ultimately determine which therapies will be most effective for specific cancers. Notable’s functional precision medicine platform will advance drug development and enable pharmaceutical companies to get new therapies to patients faster. Learn more at notablelabs.com and follow us @notablelabs.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Diagnostic kits for hematological cancer
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):